Help - Search - Members - Calendar
Full Version: Constipation
Online Medical Forum > Library Database Of Journals Publications Researches Category > Library Database Of Journals Publications Researches > Medicine Category > Internal Medicine Forum > Medicine Topics > Constipation
Pages: 1, 2, 3, 4, 5
  1. Constipation: Constipation in children (0 replies)
  2. Constipation: Overexpression of progesterone receptor b increases sensitivity of human colon muscle cells to progesterone (0 replies)
  3. Constipation: Cytologic diagnosis of metastatic seminoma to the prostate and urinary bladder: a case report (0 replies)
  4. Constipation: Correspondence: methylnaltrexone for opioid-induced constipation in advanced illness (0 replies)
  5. Constipation: A prokinetic agent, ati 7505, has shown promise for the treatment of patients with chronic idiopathic constipation (0 replies)
  6. Constipation: Peg 3350 is efficacious as a short-term treatment for functional constipation in children and adolescents (0 replies)
  7. Constipation: Evaluation of integrative medicine supplements for mitigation of chronic insomnia and constipation in an inpatient eating disorders setting. (0 replies)
  8. Constipation: Long-term clinical outcome in patients with total colonic aganglionosis: a 31-year review (0 replies)
  9. Constipation: A dual benefit of sacral neuromodulation. (0 replies)
  10. Constipation: More exercise, different diet can cure chronic constipation (0 replies)
  11. Constipation: Long-term functional outcomes after laparoscopic and open rectopexy for the treatment of rectal prolapse (0 replies)
  12. Constipation: Hypofractionated radiotherapy followed by adjuvant chemotherapy with temozolomide in elderly patients with glioblastoma (0 replies)
  13. Constipation: Peg 3350 is efficacious as a short-term treatment for functional constipation in children and adolescents,. (0 replies)
  14. Constipation: A prokinetic agent, ati 7505, * has shown promise for the treatment of patients with chronic idiopathic constipation,. (0 replies)
  15. Constipation: Exploratory study of tegaserod for dyspepsia in women receiving ppis for heartburn (0 replies)
  16. Constipation: Phase ii study of vinorelbine (alternating intravenous and oral) in combination with docetaxel as first-line chemotherapy in metastatic breast cancer (0 replies)
  17. Constipation: Constipation, critical illness and mortality: gut-derived toxidromes-real and now imagined. (0 replies)
  18. Constipation: Constipation, critical illness and mortality: gut-derived toxidromes-real and now imagined. (0 replies)
  19. Constipation: Compliance with best practice: implementing the best available evidence in the use of physical restraint in residential aged care (0 replies)
  20. Constipation: Aryx therapeutics, inc. announces successful results of chronic constipation clinical trial on ati-7505 (0 replies)
  21. Constipation: Bupropion: constipation: case report (0 replies)
  22. Constipation: Bupropion: constipation: case report. (0 replies)
  23. Constipation: The effects of melatonin on colonic transit time in normal controls and ibs patients (0 replies)
  24. Constipation: Aryx therapeutics, inc. announces successful results of chronic constipation clinical trial on ati-7505 (0 replies)
  25. Constipation: New drug approved to manage constipation. (0 replies)
  26. Constipation: Comparative study between biofeedback retraining and botulinum neurotoxin in the treatment of anismus patients (0 replies)
  27. Constipation: Patient reported and anatomical outcomes after surgery for pelvic organ prolapse (0 replies)
  28. Constipation: Irritable bowel syndrome subtypes differ in body awareness, psychological symptoms and biochemical stress markers. (0 replies)
  29. Constipation: Erythromycin lacks colon prokinetic effect in children with functional gastrointestinal disorders: a retrospective study (0 replies)
  30. Constipation: Prospective study of colonic irrigation for the treatment of defaecation disorders (0 replies)
  31. Constipation: Clinical, physiological and radiological assessment of rectovaginal septum reinforcement with mesh for complex rectocele (0 replies)
  32. Constipation: The nervous system and gastrointestinal function. (0 replies)
  33. Constipation: Chronic constipation: understanding issues in gut physiology and implications for therapy (0 replies)
  34. Constipation: Metastatic crohn's disease involving the penis (0 replies)
  35. Constipation: Left antegrade continent enema (lace): review of the literature (0 replies)
  36. Constipation: Transanal mucosectomy for endorectal pull-through in hirschsprung’s disease: comparison of abdominal, extraanal and transanal approaches (0 replies)
  37. Constipation: Helicobacter hypothesis for idiopathic parkinsonism: before and beyond (0 replies)
  38. Constipation: Subtotal colectomy with antiperistaltic cecoproctostomy for selected patients with slow transit constipation—from chinese report (0 replies)
  39. Constipation: Reinterventions after complicated or failed starr procedure (0 replies)
  40. Constipation: Observational study of children with aerophagia (0 replies)
  41. Constipation: Health tip: prevent constipation (0 replies)
  42. Constipation: Health tip: prevent constipation (0 replies)
  43. Constipation: Health tip: prevent constipation (0 replies)
  44. Constipation: Randomized, comparative efficacy trial of oral penicillin versus cefuroxime for perianal streptococcal dermatitis in children. (0 replies)
  45. Constipation: Oral administration of a centrally acting ghrelin receptor agonist to conscious rats triggers defecation (0 replies)
  46. Constipation: Clinical pharmacology of lubiprostone, a chloride channel activator in defecation disorders (0 replies)
  47. Constipation: Contributions of pain sensitivity and colonic motility to ibs symptom severity and predominant bowel habits (0 replies)
  48. Constipation: Pharmacologic treatment of constipation: what is new? (0 replies)
  49. Constipation: Duloxetine for painful diabetic neuropathy and fibromyalgia pain: systematic review of randomised trials (0 replies)
  50. Constipation: Ms essentials 25 - managing the bowel in ms (0 replies)
  51. Constipation: Diagnosis and treatment of spontaneous colonic perforation: analysis of 10 cases. (0 replies)
  52. Constipation: Serotonergic agents and the irritable bowel syndrome: what goes wrong? (0 replies)
  53. Constipation: Systematic review of randomized controlled trials of the effectiveness of biofeedback for pelvic floor dysfunction (0 replies)
  54. Constipation: Systematic review of randomized controlled trials of the effectiveness of biofeedback for pelvic floor dysfunction. (0 replies)
  55. Constipation: Regional variation in the neurochemical coding of the myenteric plexus of the human colon and changes in patients with slow transit constipation (0 replies)
  56. Constipation: [therapy of opioid-induced constipation.] (0 replies)
  57. Constipation: Peg3350 may be helpful for children with functional constipation (0 replies)
  58. Constipation: Health benefits of probiotics (0 replies)
  59. Constipation: "melanosis" in the small and large intestine. (0 replies)
  60. Constipation: Comparison of fesoterodine and tolterodine in patients with overactive bladder (0 replies)
  61. Constipation: Chronic constipation causing obstructive uropathy in an adolescent male. (0 replies)
  62. Constipation: Down syndrome and the enteric nervous system (0 replies)
  63. Constipation: Methylnaltrexone: relief for opiate-induced constipation (0 replies)
  64. Constipation: Methylnaltrexone bromide approved for opioid-induced constipation in eu. (0 replies)
  65. Constipation: Gene therapy of cav1.2 channel with vip and vip receptor agonists and antagonists: a novel approach to designing promotility and antimotility agents (0 replies)
  66. Constipation: Methylnaltrexone bromide approved for opioid-induced constipation in eu. (0 replies)
  67. Constipation: Wyeth and progenics receive approval from european commission for relistor for opioid-induced constipation in advanced illness patients (0 replies)
  68. Constipation: Pilot study of pyridostigmine in constipated patients with autonomic neuropathy (0 replies)
  69. Constipation: Long-term results of antegrade colonic enema in adult patients: assessment of functional results (0 replies)
  70. Constipation: Methylnaltrexone for the management of unwanted peripheral opioid effects (0 replies)
  71. Constipation: Temozolomide for recurrent low-grade spinal cord gliomas in adults (0 replies)
  72. Constipation: Triage presenting complaint descriptions bias emergency department waiting times. (0 replies)
  73. Constipation: European medicines agency approves relistor the first-in-class treatment of opioid-induced constipation (oic) in advanced-illness patients (0 replies)
  74. Constipation: Metabolism of omega-6 polyunsaturated fatty acids in women with dysmenorrhea. (0 replies)
  75. Constipation: European approval for relistor (0 replies)
  76. Constipation: European medicines agency approves relistorâ„¢ the first-in-class treatment of opioid-induced constipation (oic) in advanced-illness patients (0 replies)
  77. Constipation: Clinical presentation and patterns of slow transit constipation do not predict coexistent upper gut dysmotility (0 replies)
  78. Constipation: Relistor (methylnaltrexone bromide) approved in eu for opioid-induced constipation in palliative care setting (0 replies)
  79. Constipation: Wyeth pharmaceuticals-progenics drug relistor ok'd in europe (0 replies)
  80. Constipation: Studies of adolor-glaxosmithkline's entereg can resume (0 replies)
  81. Constipation: P&g quits collaboration with aryx therapeutics (0 replies)
  82. Constipation: Salix initiates phase 3 for rifaximin in non-constipation irritable bowel syndrome (0 replies)
  83. Constipation: Gastrointestinal hyper infection due to
    strongyloides stercoralis
    in a patient with behcet’s syndrome     (0 replies)
  84. Constipation: Over expression of progesterone receptor b increases the sensitivity of human colon muscle cells to progesterone. (0 replies)
  85. Constipation: P&g quits collaboration with aryx therapeutics (0 replies)
  86. Constipation: Aggressiveness and hostility in the family environment and chronic constipation in children (0 replies)
  87. Constipation: Constipation and abdominal pain. (0 replies)
  88. Constipation: Cutoff volume of dietary fiber to ameliorate constipation in children. (0 replies)
  89. Constipation: Advances in the treatment and understanding of lower gi functional disorders: an expert interview with brian e. lacy, md, phd (0 replies)
  90. Constipation: Assessing interstitial cells of cajal in slow transit constipation using cd117 is a useful diagnostic test. (0 replies)
  91. Constipation: 24-hour colonic manometry in pediatric slow transit constipation shows significant reductions in antegrade propagation (0 replies)
  92. Constipation: Is there any difference in upper gi side effects with risedronate compared to alendronate? (0 replies)
  93. Constipation: Successful physical therapy for constipation related to puborectalis dyssynergia improves symptom severity and quality of life (0 replies)
  94. Constipation: Opioid-induced constipation: a new therapeutic approach (0 replies)
  95. Constipation: Clinical and morphologic correlation after stapled transanal rectal resection for obstructed defecation syndrome (0 replies)
  96. Constipation: European chmp issues positive opinion on cymbalta for the treatment of generalised anxiety disorder (0 replies)
  97. Constipation: Clinical significance of quantitative assessment of rectoanal inhibitory reflex (rair) in patients with constipation. (0 replies)
  98. Constipation: Managing opioid-induced constipation. (0 replies)
  99. Constipation: A pilot trial with modified atkins' diet in adult patients with refractory epilepsy. (0 replies)
  100. Constipation: Gastrointestinal complaints among subjects with depressive symptoms in the general population. (0 replies)
  101. Constipation: 24-hour colonic manometry in pediatric slow transit constipation shows significant reductions in antegrade propagation (0 replies)
  102. Constipation: Research advance in functional constipation treated by acupuncture in past ten years (0 replies)
  103. Constipation: Relistor relieves constipation of palliative care patients on opioids (0 replies)
  104. Constipation: Ambulatory care for constipation in the united states, 1993–2004 (0 replies)
  105. Constipation: Life-threatening constipation induced by intrathecal baclofen therapy (0 replies)
  106. Constipation: The prevalence of nutrition impact symptoms and their relationship to quality of life and clinical outcomes in medical oncology patients (0 replies)
  107. Constipation: Methylnaltrexone for opioid-induced constipation (0 replies)
  108. Constipation: Methylnaltrexone for opioid-induced constipation (0 replies)
  109. Constipation: Lubiprostone let loose for constipation in the us (0 replies)
  110. Constipation: Common bowel problem linked to chili pepper pain receptor (0 replies)
  111. Constipation: Exercise reduces inhibitory neuroactivity and protects myenteric neurons from age-related neurodegeneration. (0 replies)
  112. Constipation: New data shows pramipexole (mirapexin®/sifrol®) can significantly reduce limb pain in patients with restless legs syndrome (rls) (0 replies)
  113. Constipation: Efficacy and safety of duloxetine in elderly women with stress urinary incontinence or stress-predominant mixed urinary incontinence. (0 replies)
  114. Constipation: The food and drug administration approves methylnaltrexone bromide for opioid-induced constipation. (0 replies)
  115. Constipation: 5-ht4 receptor activation facilitates recovery from synaptic rundown and increases transmitter release from single varicosities of myenteric neurons (0 replies)
  116. Constipation: Constipation in children should not be taken lightly (0 replies)
  117. Constipation: Methylnaltrexone for opioid-induced constipation. (0 replies)
  118. Constipation: Lubiprostone let loose for constipation in the us. (0 replies)
  119. Constipation: Methylnaltrexone for opioid-induced constipation. (0 replies)
  120. Constipation: Callisto pharmaceuticals opens phase i clinical trial of sp-304 to treat chronic constipation and irritable bowel syndrome (0 replies)
  121. Constipation: The food and drug administration approves lubiprostone for irritable bowel syndrome with constipation. (0 replies)
  122. Constipation: Methylnaltrexone appears effective for severely ill patients with opioid-induced constipation (0 replies)
  123. Constipation: Interactions of constipation, dysfunctional elimination syndrome, and vesicoureteral reflux (0 replies)
  124. Constipation: Oral methylnaltrexone is an effective treatment for opioid-induced constipation (0 replies)
  125. Constipation: European application for us constipation treatment (0 replies)
  126. Constipation: New generation compound for chronic constipation (0 replies)
  127. Constipation: Opioid-induced constipation often undiagnosed (0 replies)
  128. Constipation: [nutritional status, anthropometrical measurements, socio-economic status, and physical activity in brazilian university students.] (0 replies)
  129. Constipation: Variable response to opioid treatment: any genetic predictors within sight? (0 replies)
  130. Constipation: Oral methylnaltrexone * is an effective treatment for opioid-induced constipation,. (0 replies)
  131. Constipation: Recurrence and quality of life following perineal proctectomy for rectal prolapse (0 replies)
  132. Constipation: Methylnaltrexone for opioid-induced constipation in advanced illness (0 replies)
  133. Constipation: Twenty-four hour spatiotemporal mapping of colonic propagating sequences provides pathophysiological insight into constipation (0 replies)
  134. Constipation: World gastroenterology organisation and danone launch global campaign to improve digestive health (0 replies)
  135. Constipation: Study offers relief for sufferers of severe chronic constipation (0 replies)
  136. Constipation: Rectal diverticulum: a new complication of starr procedure for obstructed defecation (0 replies)
  137. Constipation: Medication shows promise for patients with severe chronic constipation (0 replies)
  138. Constipation: Movetis files resolor(r) with emea for the indication of chronic constipation (0 replies)
  139. Constipation: New england journal of medicine publishes results from a relistor
    phase 3 clinical study     (0 replies)
  140. Constipation: As population ages and need for palliative care grows, experts tackle new challenge for the first time at european meeting (0 replies)
  141. Constipation: Drugs ease hard-to-treat constipation (0 replies)
  142. Constipation: Drugs ease hard-to-treat constipation (0 replies)
  143. Constipation: New drug: methylnaltrexone for opioid-induced constipation (0 replies)
  144. Constipation: Drug in development: prucalopride for constipation (0 replies)
  145. Constipation: Long-term lubiprostone therapy shows positive effects on ibs-c (0 replies)
  146. Constipation: Prucalopride relieves constipation with no signs of heart risk (0 replies)
  147. Constipation: New drug eases severe constipation (0 replies)
  148. Constipation: Methylnaltrexone (relistor) provides relief for opioid-induced constipation (0 replies)
  149. Constipation: Amitiza(r) (lubiprostone) 8 mcg now available to treat irritable bowel syndrome with constipation in adult women (0 replies)
  150. Constipation: Clinical characteristics and quality of life in a cohort of 621 patients with faecal incontinence (0 replies)
This is a "lo-fi" version of our main content. To view the full version with more information, formatting and images, please click here.
Invision Power Board © 2001-2008 Invision Power Services, Inc.